Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT05497024
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 65 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Interviews — BEHAVIORALParticipants will discuss background, such as race, education, and living situation. Participants will discuss Prostate cancer Participants will discuss feedback on the educational material
- Surveys — BEHAVIORALParticipants may answer questions that are sensitive in nature.
Study Details
This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.
Key Dates
- Start date
- Aug 15, 2022
- Status verified
- Apr 2026
- Primary completion
- Feb 2, 2027
- Completion
- Feb 2, 2027
Study Design
- Enrollment
- 45 participants (estimated)
Arms
- Arm: SurveysParticipants may answer questions that are sensitive in nature.
- Arm: InterviewsThe interview may occur over phone, web conferencing, or in-person.
Primary Outcome Measure
The Ottawa Acceptability Scale [ Time Frame: through study completion and average of 1 year ]
Central Contacts
- Lisa Lowenstein, MD713-563-0020
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Lisa Lowenstein, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical ProstatectomyPHASE3 · Recruiting · yair lotan · Dallas, Texas
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Birmingham, Alabama
- Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active SurveillancePHASE3 · Recruiting · University of Texas Southwestern Medical Center · Dallas, Texas